nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—CYP3A4—bone cancer	0.88	1	CbGaD
Lomitapide—ABCB1—Cisplatin—bone cancer	0.00788	0.368	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—bone cancer	0.00528	0.246	CbGbCtD
Lomitapide—ABCB1—Methotrexate—bone cancer	0.00512	0.239	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—bone cancer	0.00316	0.148	CbGbCtD
Lomitapide—Antrafenine—PTGS2—bone cancer	0.00307	0.513	CrCbGaD
Lomitapide—Conivaptan—CYP3A4—bone cancer	0.00292	0.487	CrCbGaD
Lomitapide—Reaction gastrointestinal—Methotrexate—bone cancer	0.00188	0.0203	CcSEcCtD
Lomitapide—Rectal tenesmus—Epirubicin—bone cancer	0.00158	0.017	CcSEcCtD
Lomitapide—Hepatotoxicity—Cisplatin—bone cancer	0.00148	0.016	CcSEcCtD
Lomitapide—Rectal tenesmus—Doxorubicin—bone cancer	0.00146	0.0157	CcSEcCtD
Lomitapide—Prothrombin level increased—Epirubicin—bone cancer	0.00143	0.0155	CcSEcCtD
Lomitapide—Infection—Carboplatin—bone cancer	0.00139	0.0149	CcSEcCtD
Lomitapide—Prothrombin level increased—Doxorubicin—bone cancer	0.00133	0.0143	CcSEcCtD
Lomitapide—Proctalgia—Epirubicin—bone cancer	0.00126	0.0135	CcSEcCtD
Lomitapide—Proctalgia—Doxorubicin—bone cancer	0.00116	0.0125	CcSEcCtD
Lomitapide—Body temperature increased—Carboplatin—bone cancer	0.0011	0.0119	CcSEcCtD
Lomitapide—Anorectal discomfort—Epirubicin—bone cancer	0.00108	0.0116	CcSEcCtD
Lomitapide—Anorectal discomfort—Doxorubicin—bone cancer	0.000996	0.0107	CcSEcCtD
Lomitapide—Transaminases increased—Epirubicin—bone cancer	0.000968	0.0104	CcSEcCtD
Lomitapide—Nasal congestion—Cisplatin—bone cancer	0.000913	0.00984	CcSEcCtD
Lomitapide—Haematemesis—Methotrexate—bone cancer	0.000905	0.00975	CcSEcCtD
Lomitapide—Transaminases increased—Doxorubicin—bone cancer	0.000895	0.00964	CcSEcCtD
Lomitapide—Haematemesis—Epirubicin—bone cancer	0.000847	0.00913	CcSEcCtD
Lomitapide—Hepatomegaly—Epirubicin—bone cancer	0.000832	0.00896	CcSEcCtD
Lomitapide—Blister—Epirubicin—bone cancer	0.000817	0.0088	CcSEcCtD
Lomitapide—Hepatotoxicity—Methotrexate—bone cancer	0.000815	0.00877	CcSEcCtD
Lomitapide—Haematemesis—Doxorubicin—bone cancer	0.000784	0.00844	CcSEcCtD
Lomitapide—Dehydration—Cisplatin—bone cancer	0.000774	0.00834	CcSEcCtD
Lomitapide—Hepatomegaly—Doxorubicin—bone cancer	0.000769	0.00829	CcSEcCtD
Lomitapide—Rash erythematous—Epirubicin—bone cancer	0.000769	0.00828	CcSEcCtD
Lomitapide—Blister—Doxorubicin—bone cancer	0.000756	0.00814	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000749	0.00807	CcSEcCtD
Lomitapide—Nasopharyngitis—Cisplatin—bone cancer	0.000744	0.00801	CcSEcCtD
Lomitapide—Rash erythematous—Doxorubicin—bone cancer	0.000711	0.00766	CcSEcCtD
Lomitapide—Abdominal discomfort—Cisplatin—bone cancer	0.000689	0.00743	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Methotrexate—bone cancer	0.000665	0.00716	CcSEcCtD
Lomitapide—Blood bilirubin increased—Epirubicin—bone cancer	0.000622	0.0067	CcSEcCtD
Lomitapide—Hepatobiliary disease—Cisplatin—bone cancer	0.000606	0.00653	CcSEcCtD
Lomitapide—Gait disturbance—Epirubicin—bone cancer	0.000603	0.0065	CcSEcCtD
Lomitapide—Eructation—Epirubicin—bone cancer	0.000578	0.00623	CcSEcCtD
Lomitapide—Blood bilirubin increased—Doxorubicin—bone cancer	0.000576	0.0062	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—bone cancer	0.000569	0.00613	CcSEcCtD
Lomitapide—Urinary tract disorder—Cisplatin—bone cancer	0.000568	0.00612	CcSEcCtD
Lomitapide—Connective tissue disorder—Cisplatin—bone cancer	0.000566	0.00609	CcSEcCtD
Lomitapide—Urethral disorder—Cisplatin—bone cancer	0.000564	0.00608	CcSEcCtD
Lomitapide—Gait disturbance—Doxorubicin—bone cancer	0.000558	0.00601	CcSEcCtD
Lomitapide—Eye disorder—Cisplatin—bone cancer	0.000538	0.00579	CcSEcCtD
Lomitapide—Eructation—Doxorubicin—bone cancer	0.000535	0.00576	CcSEcCtD
Lomitapide—Cardiac disorder—Cisplatin—bone cancer	0.000534	0.00575	CcSEcCtD
Lomitapide—Ecchymosis—Epirubicin—bone cancer	0.000532	0.00573	CcSEcCtD
Lomitapide—Mediastinal disorder—Cisplatin—bone cancer	0.000519	0.00559	CcSEcCtD
Lomitapide—Malnutrition—Cisplatin—bone cancer	0.000501	0.0054	CcSEcCtD
Lomitapide—Flatulence—Cisplatin—bone cancer	0.000494	0.00532	CcSEcCtD
Lomitapide—Ecchymosis—Doxorubicin—bone cancer	0.000492	0.0053	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000491	0.00529	CcSEcCtD
Lomitapide—Muscle spasms—Cisplatin—bone cancer	0.000482	0.00519	CcSEcCtD
Lomitapide—Ill-defined disorder—Cisplatin—bone cancer	0.000465	0.00501	CcSEcCtD
Lomitapide—Anaemia—Cisplatin—bone cancer	0.000463	0.00499	CcSEcCtD
Lomitapide—Increased appetite—Epirubicin—bone cancer	0.000455	0.0049	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000455	0.0049	CcSEcCtD
Lomitapide—Malaise—Cisplatin—bone cancer	0.000452	0.00487	CcSEcCtD
Lomitapide—Dermatitis bullous—Epirubicin—bone cancer	0.000447	0.00482	CcSEcCtD
Lomitapide—Pain in extremity—Epirubicin—bone cancer	0.000427	0.0046	CcSEcCtD
Lomitapide—Myalgia—Cisplatin—bone cancer	0.000427	0.0046	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000424	0.00456	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—bone cancer	0.000422	0.00454	CcSEcCtD
Lomitapide—Discomfort—Cisplatin—bone cancer	0.000421	0.00454	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—bone cancer	0.000421	0.00453	CcSEcCtD
Lomitapide—Migraine—Epirubicin—bone cancer	0.000421	0.00453	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—bone cancer	0.000414	0.00446	CcSEcCtD
Lomitapide—Infection—Cisplatin—bone cancer	0.000406	0.00438	CcSEcCtD
Lomitapide—Nervous system disorder—Cisplatin—bone cancer	0.000401	0.00432	CcSEcCtD
Lomitapide—Dehydration—Epirubicin—bone cancer	0.000397	0.00428	CcSEcCtD
Lomitapide—Skin disorder—Cisplatin—bone cancer	0.000397	0.00428	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—bone cancer	0.000395	0.00426	CcSEcCtD
Lomitapide—Hyperhidrosis—Cisplatin—bone cancer	0.000395	0.00426	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—bone cancer	0.000394	0.00425	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—bone cancer	0.000392	0.00422	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—bone cancer	0.00039	0.0042	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—bone cancer	0.000389	0.00419	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000385	0.00414	CcSEcCtD
Lomitapide—Nasopharyngitis—Epirubicin—bone cancer	0.000382	0.00412	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—bone cancer	0.000378	0.00408	CcSEcCtD
Lomitapide—Gastritis—Epirubicin—bone cancer	0.000378	0.00407	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000377	0.00406	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000373	0.00401	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—bone cancer	0.000372	0.004	CcSEcCtD
Lomitapide—Influenza—Epirubicin—bone cancer	0.000369	0.00398	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—bone cancer	0.000368	0.00396	CcSEcCtD
Lomitapide—Paraesthesia—Cisplatin—bone cancer	0.000367	0.00396	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—bone cancer	0.000365	0.00393	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—bone cancer	0.000362	0.0039	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—bone cancer	0.000361	0.00389	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—bone cancer	0.00036	0.00387	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000356	0.00383	CcSEcCtD
Lomitapide—Decreased appetite—Cisplatin—bone cancer	0.000355	0.00383	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—bone cancer	0.000354	0.00381	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Cisplatin—bone cancer	0.000353	0.0038	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—bone cancer	0.000352	0.00379	CcSEcCtD
Lomitapide—Infestation—Methotrexate—bone cancer	0.000352	0.00379	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—bone cancer	0.00035	0.00377	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000349	0.00376	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—bone cancer	0.000344	0.00371	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—bone cancer	0.000342	0.00368	CcSEcCtD
Lomitapide—Feeling abnormal—Cisplatin—bone cancer	0.000337	0.00363	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—bone cancer	0.000335	0.00361	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—bone cancer	0.000334	0.0036	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—bone cancer	0.000333	0.00359	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—bone cancer	0.000333	0.00358	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—bone cancer	0.000329	0.00355	CcSEcCtD
Lomitapide—Infestation—Epirubicin—bone cancer	0.000329	0.00355	CcSEcCtD
Lomitapide—Body temperature increased—Cisplatin—bone cancer	0.000323	0.00348	CcSEcCtD
Lomitapide—Haematuria—Epirubicin—bone cancer	0.000314	0.00338	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—bone cancer	0.000312	0.00336	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—bone cancer	0.000311	0.00335	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—bone cancer	0.00031	0.00334	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—bone cancer	0.000309	0.00333	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—bone cancer	0.000309	0.00333	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—bone cancer	0.000305	0.00328	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—bone cancer	0.000305	0.00328	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—bone cancer	0.000295	0.00318	CcSEcCtD
Lomitapide—Asthenia—Cisplatin—bone cancer	0.000293	0.00316	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—bone cancer	0.000293	0.00316	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—bone cancer	0.000292	0.00314	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—bone cancer	0.00029	0.00313	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—bone cancer	0.00029	0.00313	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—bone cancer	0.00029	0.00312	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—bone cancer	0.000288	0.0031	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—bone cancer	0.000286	0.00308	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—bone cancer	0.000285	0.00307	CcSEcCtD
Lomitapide—Chills—Methotrexate—bone cancer	0.000283	0.00305	CcSEcCtD
Lomitapide—Diarrhoea—Cisplatin—bone cancer	0.00028	0.00301	CcSEcCtD
Lomitapide—Eye disorder—Epirubicin—bone cancer	0.000276	0.00298	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—bone cancer	0.000275	0.00296	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—bone cancer	0.000274	0.00296	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—bone cancer	0.00027	0.00291	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—bone cancer	0.000269	0.0029	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—bone cancer	0.000268	0.00289	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—bone cancer	0.000266	0.00287	CcSEcCtD
Lomitapide—Back pain—Methotrexate—bone cancer	0.000266	0.00286	CcSEcCtD
Lomitapide—Chills—Epirubicin—bone cancer	0.000265	0.00286	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—bone cancer	0.00026	0.0028	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—bone cancer	0.000257	0.00277	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—bone cancer	0.000256	0.00275	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—bone cancer	0.000255	0.00275	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—bone cancer	0.000254	0.00274	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—bone cancer	0.000254	0.00273	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—bone cancer	0.000254	0.00273	CcSEcCtD
Lomitapide—Back pain—Epirubicin—bone cancer	0.000249	0.00268	CcSEcCtD
Lomitapide—Malaise—Methotrexate—bone cancer	0.000248	0.00267	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—bone cancer	0.000247	0.00266	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—bone cancer	0.000247	0.00266	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—bone cancer	0.000246	0.00266	CcSEcCtD
Lomitapide—Chills—Doxorubicin—bone cancer	0.000245	0.00264	CcSEcCtD
Lomitapide—Nausea—Cisplatin—bone cancer	0.000243	0.00262	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—bone cancer	0.000239	0.00257	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—bone cancer	0.000238	0.00256	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—bone cancer	0.000238	0.00256	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—bone cancer	0.000235	0.00253	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—bone cancer	0.000234	0.00252	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—bone cancer	0.000234	0.00252	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—bone cancer	0.000234	0.00252	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000232	0.0025	CcSEcCtD
Lomitapide—Malaise—Epirubicin—bone cancer	0.000232	0.0025	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—bone cancer	0.000231	0.00249	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—bone cancer	0.000231	0.00249	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—bone cancer	0.00023	0.00248	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—bone cancer	0.000229	0.00247	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—bone cancer	0.000227	0.00245	CcSEcCtD
Lomitapide—Infection—Methotrexate—bone cancer	0.000223	0.0024	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—bone cancer	0.000221	0.00238	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—bone cancer	0.00022	0.00237	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—bone cancer	0.00022	0.00237	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—bone cancer	0.000219	0.00236	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—bone cancer	0.000219	0.00236	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—bone cancer	0.000219	0.00236	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—bone cancer	0.000218	0.00235	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000218	0.00234	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—bone cancer	0.000217	0.00234	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—bone cancer	0.000216	0.00233	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—bone cancer	0.000215	0.00231	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—bone cancer	0.000214	0.00231	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—bone cancer	0.000214	0.0023	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—bone cancer	0.00021	0.00227	CcSEcCtD
Lomitapide—Infection—Epirubicin—bone cancer	0.000209	0.00225	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—bone cancer	0.000206	0.00222	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000204	0.0022	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—bone cancer	0.000204	0.0022	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—bone cancer	0.000203	0.00219	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—bone cancer	0.000203	0.00218	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—bone cancer	0.000203	0.00218	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—bone cancer	0.000203	0.00218	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—bone cancer	0.000202	0.00217	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000201	0.00217	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—bone cancer	0.0002	0.00216	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—bone cancer	0.000199	0.00215	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—bone cancer	0.000198	0.00214	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—bone cancer	0.000198	0.00213	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—bone cancer	0.000195	0.0021	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000194	0.00209	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—bone cancer	0.000193	0.00208	CcSEcCtD
Lomitapide—Infection—Doxorubicin—bone cancer	0.000193	0.00208	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000191	0.00206	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—bone cancer	0.000191	0.00205	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—bone cancer	0.000189	0.00203	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—bone cancer	0.000189	0.00203	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—bone cancer	0.000188	0.00202	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—bone cancer	0.000187	0.00201	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—bone cancer	0.000185	0.00199	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—bone cancer	0.000185	0.00199	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—bone cancer	0.000184	0.00198	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—bone cancer	0.000183	0.00197	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000181	0.00195	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—bone cancer	0.000181	0.00195	CcSEcCtD
Lomitapide—Constipation—Epirubicin—bone cancer	0.00018	0.00193	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—bone cancer	0.000177	0.00191	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—bone cancer	0.000177	0.00191	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000177	0.00191	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—bone cancer	0.000174	0.00188	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—bone cancer	0.000173	0.00186	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—bone cancer	0.000173	0.00186	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—bone cancer	0.000172	0.00185	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—bone cancer	0.000171	0.00184	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—bone cancer	0.000169	0.00182	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000168	0.00181	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—bone cancer	0.000168	0.0018	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—bone cancer	0.000166	0.00179	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—bone cancer	0.000166	0.00179	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—bone cancer	0.000166	0.00179	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—bone cancer	0.000161	0.00173	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—bone cancer	0.00016	0.00172	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000159	0.00171	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—bone cancer	0.000154	0.00165	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—bone cancer	0.000154	0.00165	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—bone cancer	0.000154	0.00165	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—bone cancer	0.000151	0.00162	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—bone cancer	0.000148	0.0016	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—bone cancer	0.000144	0.00155	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—bone cancer	0.000143	0.00154	CcSEcCtD
Lomitapide—Headache—Methotrexate—bone cancer	0.000141	0.00151	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—bone cancer	0.000139	0.0015	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—bone cancer	0.000139	0.0015	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—bone cancer	0.000134	0.00144	CcSEcCtD
Lomitapide—Nausea—Methotrexate—bone cancer	0.000133	0.00144	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—bone cancer	0.000133	0.00143	CcSEcCtD
Lomitapide—Headache—Epirubicin—bone cancer	0.000132	0.00142	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—bone cancer	0.000128	0.00138	CcSEcCtD
Lomitapide—Nausea—Epirubicin—bone cancer	0.000125	0.00134	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—bone cancer	0.000124	0.00133	CcSEcCtD
Lomitapide—Headache—Doxorubicin—bone cancer	0.000122	0.00131	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—bone cancer	0.000115	0.00124	CcSEcCtD
